20160128 EGA Regulatory and Scientific Affairs Conferenc

European Commission Biotech initiative must spearhead next wave of EU biosimilar advances for patients and stimulate manufacturing

20 March 2024

Read More

Parliament compromise on pharmaceutical legislation accelerates much needed reform

19 March 2024

Read More

Parliament’s balanced stand on Unitary SPC regulation rewards innovation via an efficient Unitary SPC system that protects against access to medicines delays

28 February 2024

Read More

Changes in medicines procurement policies urgently needed to ensure secure supply of essential medicines

19 February 2024

Read More

Joint statement Association for Accessible Medicines – Medicines for Europe ahead of 5th EU-U.S. Trade and Technology Council Ministerial meeting

26 January 2024

Read More

Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use

18 January 2024

Read More

Medicines for Europe and European Business Association propose priority steps to continue the EU integration of the Ukrainе’s pharmaceutical industry

15 January 2024

Read More

The European Union cannot jeopardise patient access to generic medicines through the Urban Wastewater Treatment Directive

8 January 2024

Read More

Biosimilar medicines critical for future medicines access and sustainability but more biologic competition is needed in the EU

13 December 2023

Read More

(Original in SK) How low pricing of generic and biosimilar drugs relates to their shortage

27 November 2023

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]